SpineGuard SA (ALSGD.PA)
EUR 0.23
(-1.09%)
EUR 0.23
(-1.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.18 Million EUR | -74.79% |
| 2022 | -2.39 Million EUR | -38.75% |
| 2021 | -1.72 Million EUR | 36.5% |
| 2020 | -2.71 Million EUR | -296.13% |
| 2019 | -685.72 Thousand EUR | 70.62% |
| 2018 | -2.33 Million EUR | 43.42% |
| 2017 | -4.12 Million EUR | 1.26% |
| 2016 | -4.17 Million EUR | -7.74% |
| 2015 | -3.87 Million EUR | 14.56% |
| 2014 | -4.53 Million EUR | -29.14% |
| 2013 | -3.51 Million EUR | -7.63% |
| 2012 | -3.26 Million EUR | -27.21% |
| 2011 | -2.56 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.6 Million EUR | 0.0% |
| 2023 Q4 | -2.17 Million EUR | 0.0% |
| 2023 FY | -4.18 Million EUR | -74.79% |
| 2023 Q2 | -2 Million EUR | 0.0% |
| 2022 Q2 | -1.17 Million EUR | 0.0% |
| 2022 Q4 | -1.21 Million EUR | 0.0% |
| 2022 FY | -2.39 Million EUR | -38.75% |
| 2021 Q2 | -831.8 Thousand EUR | 0.0% |
| 2021 FY | -1.72 Million EUR | 36.5% |
| 2021 Q4 | -892.98 Thousand EUR | 0.0% |
| 2020 Q2 | -1.38 Million EUR | 0.0% |
| 2020 FY | -2.71 Million EUR | -296.13% |
| 2020 Q4 | -1.32 Million EUR | 0.0% |
| 2019 Q2 | -805.32 Thousand EUR | 0.0% |
| 2019 FY | -685.72 Thousand EUR | 70.62% |
| 2019 Q4 | 119.59 Thousand EUR | 0.0% |
| 2018 FY | -2.33 Million EUR | 43.42% |
| 2018 Q2 | -1.08 Million EUR | 0.0% |
| 2018 Q4 | -1.24 Million EUR | 0.0% |
| 2017 FY | -4.12 Million EUR | 1.26% |
| 2017 Q2 | -2.24 Million EUR | 0.0% |
| 2017 Q4 | -1.88 Million EUR | 0.0% |
| 2016 FY | -4.17 Million EUR | -7.74% |
| 2016 Q2 | -2.47 Million EUR | 0.0% |
| 2016 Q4 | -1.7 Million EUR | 0.0% |
| 2015 Q4 | -1.69 Million EUR | 0.0% |
| 2015 Q2 | -2.17 Million EUR | 0.0% |
| 2015 FY | -3.87 Million EUR | 14.56% |
| 2014 Q4 | -2.07 Million EUR | 0.0% |
| 2014 Q2 | -2.46 Million EUR | 0.0% |
| 2014 FY | -4.53 Million EUR | -29.14% |
| 2013 Q4 | -1.86 Million EUR | 0.0% |
| 2013 FY | -3.51 Million EUR | -7.63% |
| 2013 Q2 | -1.65 Million EUR | 0.0% |
| 2012 Q1 | -818.12 Thousand EUR | 0.0% |
| 2012 Q2 | -818.12 Thousand EUR | 0.0% |
| 2012 Q3 | -818.12 Thousand EUR | 0.0% |
| 2012 FY | -3.26 Million EUR | -27.21% |
| 2012 Q4 | -948.13 Thousand EUR | -15.89% |
| 2011 Q2 | -641.75 Thousand EUR | 0.0% |
| 2011 Q1 | -641.75 Thousand EUR | 0.0% |
| 2011 Q3 | -641.75 Thousand EUR | 0.0% |
| 2011 Q4 | -818.12 Thousand EUR | -27.48% |
| 2011 FY | -2.56 Million EUR | 0.0% |
| 2010 Q4 | -641.75 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Affluent Medical SA | -15.65 Million EUR | 73.274% |
| Bluelinea Société Anonyme | -1.62 Million EUR | -158.235% |
| Carmat SA | -53.86 Million EUR | 92.234% |
| Diagnostic Medical Systems S.A. | -4.94 Million EUR | 15.418% |
| Euromedis Groupe | 13.11 Million EUR | 131.909% |
| Eurobio Scientific Société anonyme | 4.83 Million EUR | 186.524% |
| Ikonisys S.A. | -2.26 Million EUR | -84.483% |
| Implanet S.A. | -6.67 Million EUR | 37.337% |
| Median Technologies SA | -22.98 Million EUR | 81.797% |
| Theraclion SA | -3.67 Million EUR | -13.834% |
| Euroapi S.A. | -189.7 Million EUR | 97.795% |
| Guerbet SA | 23.86 Million EUR | 117.529% |
| Ion Beam Applications SA | -9.11 Million EUR | 54.079% |
| Koninklijke Philips N.V. | -466 Million EUR | 99.102% |
| Sequana Medical NV | -32.56 Million EUR | 87.153% |